These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32244216)

  • 21. Stereotactic radiosurgery for symptomatic solitary cerebral cavernous malformations considered high risk for resection.
    Lunsford LD; Khan AA; Niranjan A; Kano H; Flickinger JC; Kondziolka D
    J Neurosurg; 2010 Jul; 113(1):23-9. PubMed ID: 20170299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical presentation, hemorrhage risk, and outcome in patients with familial cavernous malformations: a pragmatic prospective analysis of 75 patients.
    Alalfi MO; Lanzino G; Flemming KD
    J Neurosurg; 2023 Oct; 139(4):1018-1024. PubMed ID: 36933254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural history and imaging prevalence of cavernous malformations in children and young adults.
    Al-Holou WN; O'Lynnger TM; Pandey AS; Gemmete JJ; Thompson BG; Muraszko KM; Garton HJ; Maher CO
    J Neurosurg Pediatr; 2012 Feb; 9(2):198-205. PubMed ID: 22295927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical features of cerebral cavernous malformations patients with KRIT1 mutations.
    Denier C; Labauge P; Brunereau L; Cavé-Riant F; Marchelli F; Arnoult M; Cecillon M; Maciazek J; Joutel A; Tournier-Lasserve E; ;
    Ann Neurol; 2004 Feb; 55(2):213-20. PubMed ID: 14755725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The utility of preoperative diffusion tensor imaging in the surgical management of brainstem cavernous malformations.
    Flores BC; Whittemore AR; Samson DS; Barnett SL
    J Neurosurg; 2015 Mar; 122(3):653-62. PubMed ID: 25574568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
    Girard R; Li Y; Stadnik A; Shenkar R; Hobson N; Romanos S; Srinath A; Moore T; Lightle R; Shkoukani A; Akers A; Carroll T; Christoforidis GA; Koenig JI; Lee C; Piedad K; Greenberg SM; Kim H; Flemming KD; Ji Y; Awad IA
    Neurosurgery; 2021 Feb; 88(3):686-697. PubMed ID: 33469662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level.
    Flemming KD; Kumar S; Brown RD; Singh RJ; Whitehead K; McCreath L; Lanzino G
    Cerebrovasc Dis; 2020; 49(2):216-222. PubMed ID: 32348981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.
    Polster SP; Stadnik A; Akers AL; Cao Y; Christoforidis GA; Fam MD; Flemming KD; Girard R; Hobson N; Koenig JI; Koskimäki J; Lane K; Liao JK; Lee C; Lyne SB; McBee N; Morrison L; Piedad K; Shenkar R; Sorrentino M; Thompson RE; Whitehead KJ; Zeineddine HA; Hanley DF; Awad IA
    Neurosurgery; 2019 Dec; 85(6):843-853. PubMed ID: 30476251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Asymptomatic cerebral cavernous angiomas associated with plasma marker signature.
    Chehuen Bicalho V; da Fontoura Galvão G; Lima Fontes-Dantas F; Paulo da Costa Gonçalves J; Dutra de Araujo A; Carolina França L; Emílio Corrêa Leite P; Campolina Vidal D; Castro Filho R; Vieira Alves-Leon S; Marcondes de Souza J
    J Clin Neurosci; 2021 Jul; 89():258-263. PubMed ID: 34119277
    [No Abstract]   [Full Text] [Related]  

  • 30. Intracranial cavernous malformations.
    Rivera PP; Willinsky RA; Porter PJ
    Neuroimaging Clin N Am; 2003 Feb; 13(1):27-40. PubMed ID: 12802939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of intracranial and spinal cavernous malformations: a study of prevalence and natural history.
    Cohen-Gadol AA; Jacob JT; Edwards DA; Krauss WE
    J Neurosurg; 2006 Mar; 104(3):376-81. PubMed ID: 16572649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medullary hemorrhage that preceded the onset of multiple cavernous angiomas.
    Naoi T; Nakao K; Nakamura Y; Ando A; Kawakami T
    Intern Med; 2015; 54(7):843-6. PubMed ID: 25832954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of the venous angioarchitecture of multiple cerebral cavernous malformations with familial or sporadic disease: a susceptibility-weighted imaging study with 7-Tesla MRI.
    Dammann P; Wrede K; Zhu Y; Matsushige T; Maderwald S; Umutlu L; Quick HH; Hehr U; Rath M; Ladd ME; Felbor U; Sure U
    J Neurosurg; 2017 Feb; 126(2):570-577. PubMed ID: 27153162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morbidity After Symptomatic Hemorrhage of Cerebral Cavernous Malformation: A Nomogram Approach to Risk Assessment.
    Ma L; Zhang S; Li Z; Wu CX; Wang Z; Zhan L; Hao Q; Wang H; Ye X; Chen X; Liu YO; Wang S; Zhao YL
    Stroke; 2020 Oct; 51(10):2997-3006. PubMed ID: 32951540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course of patients with conservatively managed cerebral cavernous malformations.
    Sandmann ACA; Kempeneers MA; van den Berg R; Verbaan D; Vandertop WP; Coutinho JM
    Eur Stroke J; 2024 Sep; 9(3):667-675. PubMed ID: 38624046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical features and management of cavernous and venous angiomas in the head].
    Tokunaga K; Date I
    Brain Nerve; 2011 Jan; 63(1):17-25. PubMed ID: 21228444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cause is the main predictor of outcome in patients with pontine hemorrhage.
    Rabinstein AA; Tisch SH; McClelland RL; Wijdicks EF
    Cerebrovasc Dis; 2004; 17(1):66-71. PubMed ID: 14530640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemorrhage risks and functional outcomes of untreated brainstem cavernous malformations.
    Li D; Hao SY; Jia GJ; Wu Z; Zhang LW; Zhang JT
    J Neurosurg; 2014 Jul; 121(1):32-41. PubMed ID: 24785325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solitary Sporadic Cerebral Cavernous Malformations: Risk Factors of First or Recurrent Symptomatic Hemorrhage and Associated Functional Impairment.
    Dammann P; Jabbarli R; Wittek P; Oppong MD; Kneist A; Zhu Y; Wrede K; Müller O; Forsting M; Sure U
    World Neurosurg; 2016 Jul; 91():73-80. PubMed ID: 27058610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic radiosurgery for deep-seated cavernous malformations: a move toward more active, early intervention. Clinical article.
    Nagy G; Razak A; Rowe JG; Hodgson TJ; Coley SC; Radatz MW; Patel UJ; Kemeny AA
    J Neurosurg; 2010 Oct; 113(4):691-9. PubMed ID: 20433275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.